What is myoepithelial carcinoma of the salivary gland?
Myoepithelial carcinoma is a rare salivary gland cancer. It is also known as malignant myoepithelioma.
Salivary glands contain two main kinds of lining cell. Ductal cells line the small tubes that carry saliva. Myoepithelial cells wrap around these tubes and squeeze to push saliva out. In myoepithelial carcinoma, the cancer cells look and behave almost entirely like myoepithelial cells.
The tumour usually appears as a slow-growing, painless lump, most often in the parotid gland in front of the ear (Vilar-Gonzalez et al., 2015). It mostly affects adults over 50, and men and women are affected in similar numbers (Lavareze et al., 2023).
About half of myoepithelial carcinomas develop inside a long-standing benign pleomorphic adenoma (a benign mixed tumour). The rest arise de novo, without an earlier lump. In the past many of these cancers were labelled “malignant mixed tumour”, so the disease was probably under-recognised (Savera et al., 2000).
Behaviour varies widely. Some tumours stay local for years, while others come back after surgery or spread to the lungs. Treatment is mainly surgery with clear margins, often followed by radiotherapy.
1. Key facts at a glance
| Feature | Details |
|---|---|
| Type of cancer | Salivary gland carcinoma made almost entirely of myoepithelial cells |
| Also called | Malignant myoepithelioma |
| How common | Rare; a small percentage of salivary gland cancers |
| Typical age | Mostly over 50; mean in the mid-50s |
| Sex | Men and women affected about equally |
| Main site | Parotid gland (about half); also submandibular and minor salivary glands |
| Origin | Within a pleomorphic adenoma, or de novo |
| Main treatment | Surgery, often with radiotherapy |
| Outlook | Variable; roughly half alive at 5 years in pooled reports |
2. Types of myoepithelial carcinoma
By origin
| Type | Description |
|---|---|
| De novo | Arises without a known earlier tumour |
| Myoepithelial carcinoma ex pleomorphic adenoma | Develops within a benign mixed tumour; a common form |
| Arising from a benign myoepithelioma | Less common |
By cell type
The cancer cells can take on several shapes, and many tumours contain a mixture.
| Cell type | Appearance | Notes |
|---|---|---|
| Epithelioid | Rounded or polygonal cells | Common |
| Clear | Pale, glycogen-rich cytoplasm | Seen in about 4 in 10 cases |
| Spindle | Long, slender cells | Can mimic a sarcoma |
| Plasmacytoid (hyaline) | Cells with an off-centre nucleus and glassy cytoplasm | Linked to shorter disease-free survival |
| Mixed | Combination of the above | Frequent |
In a systematic review of 71 patients, plasmacytoid cells and a solid growth pattern were associated with earlier recurrence (Lavareze et al., 2023).
By grade
Tumours may be low grade or high grade under the microscope. High-grade tumours are more likely to spread.
How it differs from related salivary tumours
| Tumour | Key difference |
|---|---|
| Benign myoepithelioma | Same cells but no invasion of surrounding tissue |
| Pleomorphic adenoma | Benign; contains both ductal and myoepithelial cells with cartilage-like stroma |
| Epithelial-myoepithelial carcinoma | Two-layer structure of ductal and myoepithelial cells |
| Carcinoma ex pleomorphic adenoma (other types) | The cancerous part is not myoepithelial, for example salivary duct carcinoma |
| Adenoid cystic carcinoma | Has a typical sieve-like pattern and MYB gene changes |
The salivary glands
| Gland | Position | Share of myoepithelial carcinomas |
|---|---|---|
| Parotid | In front of and below the ear | The largest share, about half |
| Submandibular | Under the jaw | Less common |
| Sublingual | Under the tongue | Rare |
| Minor salivary glands | Hundreds of tiny glands in the palate, cheeks, lips, throat and nose | A notable minority, especially the palate |
The facial nerve, which controls the muscles of facial expression, runs through the parotid gland. This is why parotid tumours and their treatment can affect facial movement.
3. Causes and risk factors
The exact cause is unknown.
| Factor | Notes |
|---|---|
| Long-standing pleomorphic adenoma | Especially one present for many years or that has recurred |
| Age over 50 | Most patients are older adults |
| Previous radiotherapy to the head and neck | Increases the risk of salivary gland cancers generally |
| Gene changes | Some tumours carry PLAG1 or HMGA2 changes (from a mixed tumour) or EWSR1 fusions |
Myoepithelial carcinoma is not inherited, and no lifestyle factor has been clearly linked to it.
4. How does it look
From the outside
| Feature | Description |
|---|---|
| Lump | Firm swelling in front of or below the ear, under the jaw, or in the mouth |
| Growth | Slow at first; may speed up |
| Skin | Usually normal; may become fixed or red in advanced cases |
| Face | Weakness on one side if the facial nerve is involved |
On scans
Ultrasound, MRI and CT show a lump that may look well defined or irregular. MRI is useful for showing whether the tumour has spread along nerves or into the deep part of the parotid.
Under the microscope
| Feature | Description |
|---|---|
| Growth pattern | Multiple nodules, often with a crowded rim of cells and a central area of dead or myxoid tissue |
| Cells | Epithelioid, clear, spindle or plasmacytoid |
| Background | Myxoid (jelly-like) or hyalinised (glassy) material |
| Invasion | Infiltrates surrounding tissue; may involve nerves |
| Stains | Positive for cytokeratins, S100 and vimentin; often SOX10, calponin, p63 and smooth muscle actin |
In the series of 25 patients reported by Savera and colleagues, all tumours grew in an infiltrative way, and most had the typical multinodular pattern (Savera et al., 2000).
5. Symptoms
Common symptoms
- A painless lump in front of or below the ear
- A lump under the jaw
- A swelling in the mouth or palate (for minor salivary glands)
- Change in an old lump, such as sudden growth
Less common symptoms
| Symptom | What it may mean |
|---|---|
| Pain | Nerve involvement or rapid growth |
| Facial weakness or drooping | Involvement of the facial nerve |
| Numbness | Nerve involvement |
| Lumps in the neck | Possible lymph node spread |
| Cough or breathlessness | Possible lung spread |
Because these cancers are often painless, people may wait months or even years before seeing a doctor (Vilar-Gonzalez et al., 2015).
When to seek medical advice
See a doctor about any lump near the ear, under the jaw or in the mouth that lasts more than three weeks, and especially if an old lump starts to grow, becomes painful, or if you notice facial weakness.
6. Diagnosis
| Test | Purpose |
|---|---|
| Ultrasound | First scan for a salivary gland lump |
| Fine needle aspiration or core biopsy | Samples the lump; diagnosis may be difficult on a small sample |
| MRI | Shows local extent and nerve involvement |
| CT of the neck and chest | Checks lymph nodes and lungs |
| PET-CT | In selected high-grade tumours |
| Final pathology after surgery | Often needed to confirm the diagnosis |
Needle samples can be hard to interpret, because the cells may look bland and the background material can resemble a benign mixed tumour (Argyris and Wakely, 2023).
Staging
Myoepithelial carcinoma of a major salivary gland is staged with the TNM system for salivary gland cancers. It takes into account tumour size, spread beyond the gland, lymph nodes and distant spread.
7. Treatment
Treatment is planned by a head and neck cancer team.
Surgery
| Situation | Usual operation |
|---|---|
| Tumour in the outer parotid | Superficial or partial parotidectomy |
| Tumour in the deep parotid or larger tumour | Total parotidectomy, keeping the facial nerve if possible |
| Submandibular gland | Removal of the gland |
| Minor salivary gland | Wide local excision, sometimes with bone removal |
| Lymph node spread | Neck dissection |
| High-grade tumour | Neck dissection may be offered even if nodes look normal |
The facial nerve is preserved unless the cancer is growing into it.
Radiotherapy
| Situation | Role |
|---|---|
| Close or positive margins | Lowers the risk of local recurrence |
| High-grade tumour | Often advised |
| Nerve or vessel invasion | Often advised |
| Lymph node spread | Treats the neck |
In pooled data, patients treated with more than one type of treatment, such as surgery plus radiotherapy, had longer disease-free survival (Lavareze et al., 2023).
Drug treatment
There is no standard chemotherapy. For spread to other organs, doctors may use platinum-based chemotherapy, or targeted drugs if testing finds a suitable change. Clinical trials should be considered.
Side effects
| Treatment | Possible side effects |
|---|---|
| Parotid surgery | Temporary facial weakness, numbness of the earlobe, sweating while eating (Frey syndrome) |
| Neck dissection | Shoulder stiffness, neck numbness |
| Radiotherapy | Dry mouth, sore skin, taste changes, hearing changes |
What treatment involves day to day
| Stage | What to expect |
|---|---|
| Surgery | 1-3 nights in hospital, with a drain for a day or two |
| Recovery | Several weeks; facial weakness, if any, often improves over months |
| Radiotherapy | Weekday sessions for around 6 weeks |
| After radiotherapy | Dental care and mouth care are important |
8. Outlook (prognosis)
The outlook ranges from long-term cure to aggressive disease.
| Measure | Reported results |
|---|---|
| 2-year overall survival | About two-thirds (Lavareze et al., 2023) |
| 5-year overall survival | Just under half in pooled data (Lavareze et al., 2023) |
| Recurrence | Common, often more than once |
| Metastasis | Mainly to the lungs; more often with high-grade tumours |
In the Savera series, nearly half of the patients with follow-up developed metastases, and most of those had high-grade tumours (Savera et al., 2000).
| Factor | Effect |
|---|---|
| High grade | Poorer outlook |
| Plasmacytoid cells or solid pattern | Shorter time to recurrence |
| Clear surgical margins | Better local control |
| Combined treatment | Longer disease-free survival |
Why recurrence happens
Myoepithelial carcinoma often grows as several nodules with an infiltrative edge. Small extensions of tumour may reach beyond the main lump, and some tumours follow nerves. If any of these are left behind, the cancer can regrow, sometimes more than once. This is why surgeons aim for a margin of normal tissue and why radiotherapy is frequently added.
9. Follow-up
| Follow-up | Purpose |
|---|---|
| Clinic visits every 2-3 months in year 1 | Examination of the surgical site and neck |
| Then every 3-6 months up to year 5 | Less frequent visits over time |
| MRI of the head and neck | Looks for local recurrence |
| Chest CT | Looks for lung spread, especially with high-grade tumours |
| Long-term follow-up | Recurrence can occur late |
10. Living with myoepithelial carcinoma
- Do facial exercises if a physiotherapist recommends them for facial weakness
- Protect your eye with drops and a shield at night if you cannot close it fully
- Keep up dental checks after radiotherapy and use fluoride as advised
- Sip water often and use saliva substitutes if your mouth is dry
- Report new lumps, pain or a cough between appointments
- Stop smoking, which slows healing and worsens radiotherapy side effects
- Seek support from head and neck cancer groups
11. Frequently asked questions
| Question | Answer |
|---|---|
| Is it the same as a benign myoepithelioma? | No; the carcinoma invades surrounding tissue and can spread |
| Did my old lump turn into cancer? | That happens in a proportion of cases; others arise without an earlier lump |
| Will I lose movement in my face? | Surgeons try hard to save the facial nerve; weakness is often temporary |
| Will I need radiotherapy? | Often, especially for high-grade tumours or close margins |
| Can it spread? | Yes, most often to the lungs |
| Is it inherited? | No |
| Why was it hard to diagnose? | The cells can look bland and resemble benign tumours on needle samples |
| Will I need chemotherapy? | Not usually; it is reserved for cancer that has spread |
| How long is follow-up? | Usually at least 5 years, and often longer |
12. Questions to ask your care team
- Did my cancer arise in a pleomorphic adenoma or de novo?
- Is it low grade or high grade?
- Were the margins clear?
- Is my facial nerve at risk?
- Do I need radiotherapy or neck surgery?
- How often will I need scans of the chest?
- Would genetic testing of the tumour change my treatment?
Resources
- Argyris, P.P. and Wakely, P.E. Jr (2023) ‘Cytopathology of salivary gland myoepithelial carcinoma: a study of 13 cases and review of the literature’, Journal of the American Society of Cytopathology, 12(6), pp. 461-468.
- Lavareze, L. et al. (2023) ‘Clinicopathological and survival profile of patients with salivary gland myoepithelial carcinoma: a systematic review’, Journal of Oral Pathology and Medicine, 52(2), pp. 101-108.
- Savera, A.T. et al. (2000) ‘Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 25 patients’, American Journal of Surgical Pathology, 24(6), pp. 761-774.
- Vilar-Gonzalez, S. et al. (2015) ‘Salivary gland myoepithelial carcinoma’, Clinical and Translational Oncology, 17(11), pp. 847-855.
- National Cancer Institute (2026) Salivary Gland Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/head-and-neck/hp/adult/salivary-gland-treatment-pdq (Accessed: October 2026).
Prepared by the editorial team, October 2026.